New shot aims to tame dangerous blood fats

NCT ID NCT06555640

Completed Disease control Sponsor: Zhejiang Doer Biologics Co., Ltd. Source: ClinicalTrials.gov ↗

Summary

This study tested a new injectable drug called DR10624 to see if it could safely lower very high levels of triglycerides, a type of fat in the blood. It involved 79 adults with severe hypertriglyceridemia, who received either the drug or a placebo (dummy shot) for 12 weeks. The main goal was to see how much the drug reduced triglyceride levels and to check for side effects.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Baoding No.1 Central Hospital

Baoding, China
Chifeng Municipal Hospital

Chifeng, China
Daqing People's Hospital

Daqing, China
Huzhou Central Hospital

Huzhou, China
Inner Mongolia People's Hospital.

Hohhot, China
Lishui Municipal Central Hospital

Lishui, China
Luoyang Third Peoples Hospital

Luoyang, China
Meihekou Central Hospital

Meihekou, China
Nanyang Central Hospital

Nanyang, China
Panjin Liaoyou Baoshihua Hospital

Panjin, China
Peking University First Hospital

Beijing, China
Pingxiang People's Hospital

Pingxiang, China
Second Xiangya Hospital of Central South University

Changsha, China
Shaanxi Provincial People's Hospital

Xi'an, China
The Affiliated Hospital of Hangzhou Normal University

Hangzhou, China
The Affiliated Hospital of Nantong University

Nantong, China
The Affiliated Hospital of Xuzhou Medical University

Xuzhou, China
The First Affiliated Hospital of Baotou Medical College

Baotou, China
The First Affiliated Hospital of Bengbu Medical University

Bengbu, China
The First Affiliated Hospital of Henan University of Science and Technology

Luoyang, China
The First Affiliated Hospital of South China University

Hengyang, China
The First Hospital of Jilin University

Changchun, China
The Fourth Hospital of Harbin Medical University

Harbin, China
The People's Hospital of Liaoning Province

Shenyang, China
The Second Affiliated Hospital of Nanjing Medical University

Nanjing, China
The Second Affiliated Hospital to Nanchang University

Nanchang, China
The Second Hospital of Jilin University

Changchun, China
The Third Affiliated Hospital of Xinjiang Medical University

Xinxiang, China
The Third Hospital of Nanchang

Nanchang, China
Yancheng First People's Hospital

Yancheng, China
Yixing People's Hospital

Yixing, China
Yiyang Central Hospital

Yiyang, China
Yueyang Central Hospital

Yueyang, China
Yuncheng Central Hospital

Yuncheng, China
Zibo Municipal Hospital

Zibo, China

Conditions

Explore the condition pages connected to this study.

SEVERE HYPERTRIGLYCERIDEMIA